Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ko

Showing results (1011-1020 of 1,128) with videos related to

Pageof 113
Sort By:
Journal of Neurosurgery. Spine|November 14, 2025
Effect of early mobilization on 30-day wound complications following sacral amputation for en bloc tumor resectionNishanth S Sadagopan, Rahul K Chaliparambil, Rebecca Du, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)M Kundranda, A C Gracian, S F Zafar, et al.
British Journal of Cancer|March 31, 2005
Nasal-type NK/T cell lymphoma: clinical features and treatment outcomeJ Lee, W S Kim, Y H Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor riskAtsushi Kaneda, Chiaochun J Wang, Raymond Cheong, et al.
Physical Review Letters|August 7, 2012
Suppression of edge localized modes in high-confinement KSTAR plasmas by nonaxisymmetric magnetic perturbationsY M Jeon, J-K Park, S W Yoon, et al.
Comptes Rendus Biologies|January 28, 2004
The NIA cDNA project in mouse stem cells and early embryosMark G Carter, Yulan Piao, Dawood B Dudekula, et al.
Breast Cancer Research and Treatment|February 15, 2016
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignanciesAmy Jo Chien, Alyson Cockerill, Craig Fancourt, et al.
European Journal of Haematology|August 2, 2006
Prognostic factor analysis and proposed prognostic model for conventional treatment of high-grade primary gastric lymphomaYeon H Park, Won S Kim, Soo M Bang, et al.
Gut|April 29, 2009
Standard steroid treatment for autoimmune pancreatitisT Kamisawa, T Shimosegawa, K Okazaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 casesJ Y Hong, M E Hong, M K Choi, et al.
Pageof 113

Showing results (1011-1020 of 1,128) with videos related to

Sort By:
Pageof 113
Journal of Neurosurgery. Spine|November 14, 2025
Effect of early mobilization on 30-day wound complications following sacral amputation for en bloc tumor resectionNishanth S Sadagopan, Rahul K Chaliparambil, Rebecca Du, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)M Kundranda, A C Gracian, S F Zafar, et al.
British Journal of Cancer|March 31, 2005
Nasal-type NK/T cell lymphoma: clinical features and treatment outcomeJ Lee, W S Kim, Y H Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor riskAtsushi Kaneda, Chiaochun J Wang, Raymond Cheong, et al.
Physical Review Letters|August 7, 2012
Suppression of edge localized modes in high-confinement KSTAR plasmas by nonaxisymmetric magnetic perturbationsY M Jeon, J-K Park, S W Yoon, et al.
Comptes Rendus Biologies|January 28, 2004
The NIA cDNA project in mouse stem cells and early embryosMark G Carter, Yulan Piao, Dawood B Dudekula, et al.
Breast Cancer Research and Treatment|February 15, 2016
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignanciesAmy Jo Chien, Alyson Cockerill, Craig Fancourt, et al.
European Journal of Haematology|August 2, 2006
Prognostic factor analysis and proposed prognostic model for conventional treatment of high-grade primary gastric lymphomaYeon H Park, Won S Kim, Soo M Bang, et al.
Gut|April 29, 2009
Standard steroid treatment for autoimmune pancreatitisT Kamisawa, T Shimosegawa, K Okazaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 casesJ Y Hong, M E Hong, M K Choi, et al.
Pageof 113